Clinical Trial Update: Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

View source ↗

Summary

An update on the MIDAS clinical trial focusing on myeloperoxidase and multi-marker diagnostics for Acute Coronary Syndrome, detailing sample procurement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Abbott RDx Cardiometabolic | Conditions: Acute Coronary Syndrome (ACS) | Status: COMPLETED